CCK-8 and Transwell experimental results displayed that MSCs-EVs inhibited the proliferative, migration and invasive capabilities of NSCLC cells, which, conversely, were promoted by overexpressing THBS2 (Fig. 7C–E). Here, THBS2 is linked to non-small cell lung carcinoma.